John Renger, Chief Scientific Officer at Cerevel Therapeutics Holdings, Inc. (CERE), sold 4,322 shares at $41.54 ($180K) on 2024-02-07, disclosed to the SEC on 2024-02-08.
Open-market sale of $180k CERE by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.54 | 2,161 | $90K | 50.0% |
| 2 | $41.54 | 2,161 | $90K | 50.0% |
| Total | $41.54 avg | 4,322 | $180K | 100% |
| Filing → |
| CERE | SELL | 2022-08-12 | $4.5M | — | Filing → |
| CERE | SELL | 2022-08-09 | $1.0M | — | Filing → |
| CERE | SELL | 2022-07-22 | $750K | — | Filing → |